REGN
REGN
NASDAQ · Biotechnology

Regeneron Pharmaceuticals

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$623.43
+5.40 (+0.87%)
As of Jun 24, 9:32 PM ET ·
Analyst Consensus
Buy
38
Analysts
Very High
Coverage
Buy 27 71%
Hold 11 29%
Sell 0 0%
Price Target
Analyst Price Target -87.7% upside
Low Target $61.79
Average Target $76.80
High Target $111.17
Current Price $623.43
Current
$623.43
Target
$76.80
$61.79 $76.80 avg $111.17
Scenario Analysis
Bear Case
$61.79
-90.1%
Low target
Base Case
$76.80
-87.7%
Avg target
Bull Case
$111.17
+-82.2%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$821.11
-24.1% from high
52-Week Low
$503.25
+23.9% from low
50-Day SMA
$763.91
-18.4% vs SMA
200-Day SMA
$631.14
-1.2% vs SMA
RSI (14)
59.8
Neutral
Target vs 52W High
$76.80
-90.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%